Highlighted content short description.
The first infusion of an investigational drug that aims to delay or help to prevent the earliest memory loss due to Alzheimer’s disease took place in September at Butler Hospital in Providence, R.I., researchers announced. September 25, 2020.
Providence Journal, September 23, 2020
New study initiated in the U.S. for people who have intermediate or elevated levels of amyloid in their brains. Eisai, July 14, 2020.
Providence Journal, July 14, 2020
